Chemsex: a clinical reality, not a moral failure
Chemsex is the intentional use of psychoactive substances immediately before or during sex to enhance and prolong sexual activity, and it sits at a complex intersection of substance use and sexual behavior that calls for clinical understanding rather than moral judgment. When psychologists treat chemsex as a public health scandal instead of a lived, often pleasurable practice, they shut down the very conversations that could protect clients’ sexual and mental health. History has long pathologised sex between men, and sensationalised portrayals of chemsex repeat that harm by focusing only on risk and “moral panic.” At its heart, chemsex is “a new iteration of very old human need, behaviours and desires,” not a diagnostic category. Our job is not to decide whether clients should have sex on drugs, but to help them understand what chemsex means in their lives.
How chemsex works – and why people use it
Chemsex typically involves drugs such as crystal methamphetamine, mephedrone, and GBL/GHB, alongside other substances like stimulants, ketamine, poppers, cocaine, and MDMA. Sessions often happen in homes, sex-on-site venues, or hotel rooms, can run over a weekend, and are frequently arranged through geo-spatial dating or hook-up apps. Evidence suggests that around 25 per cent of men who have sex with men have had chemsex, yet outcomes vary widely. Some people experience increased pleasure, intimacy, and a sense of control; others face sexual health risks, overdoses, or drug-induced psychosis when stimulant use escalates. In parallel, meth use among gay and bisexual men is rising as a silent epidemic, often entwined with sex. Understanding this continuum – from positive to harmful – is central to chemsex and mental health work. A matched care approach recognises that not everyone who uses chems needs crisis intervention, but everyone deserves thoughtful, tailored support.
Stigma, shame, and the psychologist–drug–sex conversation
The biggest barrier to helpful chemsex and mental health work is not the drugs themselves, but the shame that surrounds them. One client avoided even saying the word “meth,” referring instead to “acting out,” because the term carried so much stigma that speaking it aloud made him shut down. Many gay and bisexual men use substances to numb shame, only to feel more shame when drinking or drug use leads to blackouts, avoided intimacy, or risky sex. Services that moralise sex, sexuality, and drug use add layers of taboo and othering, leaving individuals isolated and reluctant to seek help. As psychologists, we must examine our own attitudes to sex and drugs, because discomfort on our side is quickly felt by clients. A nonjudgmental, client-centred psychologist drug conversation is not optional; it is a core clinical skill in sexual health and substance use sexual behavior work.
Moving from crisis response to early, client-centred exploration
Too many clients believe they must wait for catastrophe – an overdose, an HIV diagnosis, a relationship breakdown – before questioning their relationship with chems, meth, or alcohol. In reality, “we’re allowed to question our relationship with drinking or using drugs long before it becomes a problem.” When a high-functioning client noticed his monthly meth use was becoming ego-dystonic, blocking vulnerability and intimacy with other gay men, therapy became a space to examine that discomfort. To make exploration possible, his therapist took loaded words like meth, addiction, and abstinence off the table at first, creating safety to talk without feeling pushed toward a predetermined goal. This is clinical psychology sexual health practice at its best: helping clients make sense of substance use sexual behavior before they reach crisis, and recognising that a change in meaning – not only in frequency – can signal when support is needed.
Using clinical frameworks that honour agency and diversity
Clinical frameworks now support psychologists to respond to chemsex without flattening it into pathology. A resilience framework foregrounds how health outcomes vary, how some people practice chemsex safely, and how individuals retain agency in managing personal risk. Recommendations for psychologists, co-produced with people who have lived experience of chemsex, outline roles across prevention, improving psychological outcomes, addressing health inequalities, and shaping culturally sensitive services. This work insists that chemsex is not inevitably problematic; risks depend on frequency of sessions, drugs used, and pre-existing vulnerabilities. Understanding the drivers of chemsex helps us see why some people use safely and happily while others need support, and it underpins a matched care approach tailored to individual needs. The clinical task is to integrate substance use, sexuality, and mental health into one coherent conversation that respects sexual expression while still taking harms seriously.
